Advertisement

Topics

FDA Approves Smart Continuous Glucose Monitoring System

16:48 EDT 13 Mar 2018 | Pharmacy Times

Officials with the FDA have approved Medtronic’s continuous glucose monitoring (CGM) system (Guardian Connect) for use by individuals living with diabetes, according to a company press release.
 

Original Article: FDA Approves Smart Continuous Glucose Monitoring System

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Smart Continuous Glucose Monitoring System"

Advertisement
Quick Search
Advertisement
Advertisement